Medication use patterns in pregnant women with psoriasis: a nationwide study in Taiwan

Author:

Ou Chien-Hua12,Kao Li-Ting134ORCID,Yang Hui-Wen145,Chiang Yi-Lin1,Wen Yuan-Liang145,To Sheng-Yin145,Chen Yi-Hsien6

Affiliation:

1. School of Pharmacy, National Defense Medical Center , Taipei , Taiwan

2. Department of Clinical Pharmacy, Tri-Service General Hospital Penghu Branch , Penghu , Taiwan

3. Department of Pharmacy Practice, Tri-Service General Hospital , Taipei , Taiwan

4. Graduate Institute of Life Sciences, National Defense Medical Center , Taipei , Taiwan

5. School of Public Health, National Defense Medical Center , Taipei , Taiwan

6. Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center , Taipei , Taiwan

Abstract

Abstract Background Psoriasis, an autoimmune skin condition, affects 2–4% of the global population, with significant prevalence among women of childbearing age. Pregnancy presents challenges in managing psoriasis because of hormonal changes and treatment safety concerns. Understanding treatment patterns in pregnant women is crucial, given limited real-world evidence. Objectives To explore the utilization patterns of medications among pregnant women diagnosed with psoriasis within real-world data, utilizing data sourced from a nationwide database in Taiwan. Methods This nationwide study utilized Taiwan's National Health Insurance (NHI) database and birth certificate application records. It included registered pregnant women diagnosed with psoriasis from 2005 to 2014. Medication usage was tracked 3 years before conception to 3 years after delivery. Medications were categorized based on Anatomical Therapeutic Chemical codes, and statistical analyses were conducted using SAS software. Results In total, 30 267 pregnant women with psoriasis were studied. In total, 11 651 (38.5%) mothers had received ≥ 1 prescription during follow-up (exposed group) and 61.5% (18 616) had never received medication (unexposed group). Demographics and comorbidities were similar between these two groups. Topical corticosteroids were the most prescribed treatment, followed by phototherapy, with systemic drugs and biologics less common. During the study period, 11 096 women with psoriasis had used topical corticosteroids, 3376 had used nonsteroidal topical agents, 218 had used systemic agents or biologics and 519 had received treatment with phototherapy. Medication usage declined during pregnancy, reaching its lowest in the third trimester but rebounded postpartum. Conclusions Psoriasis medications, systemic, biological or topical, were largely discontinued during pregnancy, sometimes up to 2 years before and extending postpartum. Research is needed to understand its impact on maternal and child health.

Funder

Ministry of Science and Technology, Taiwan

Publisher

Oxford University Press (OUP)

Reference30 articles.

1. Psoriasis;Armstrong;JAMA Dermatol,2017

2. Psoriasis;Weigle;Am Fam Physician,2013

3. Psoriasis;Boehncke;Lancet,2015

4. Psoriasis;Nestle;N Engl J Med,2009

5. Psoriasis in pregnancy: a review (I);Ruiz;Actas Dermosifiliogr,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3